Advertisement

Topics

Search Results for "April 2013 Update On Transvaginal Mesh Lawsuits"

07:34 EDT 28th June 2016 | BioPortfolio

Matching Channels

Proliferation inducing ligand APRIL

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

iBioLaunch

The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and ...

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

Kinases Raf Inhibitors

The Ras-Raf-MEK-ERK (ERK) pathway is a logical therapeutic target because it represents a common downstream pathway for several key growth factor tyrosine kinase receptors which are often mutated or...

Matching News

J&J Agrees to Pay Over $120M to Settle Thousands of Mesh Lawsuits

Johnson & Johnson offered a large settlement to resolve its first big group of transvaginal mesh lawsuits, Bloomberg reported. The company agreed to settle as many as 3,000 cases for more than $12...

J&J Takes $12.5 M Hit in Philly Transvaginal Mesh Trial

Johnson & Johnson’s Ethicon unit took a multi-million dollar trial loss over its transvaginal mesh implant at the end of last year, and 2016 started off with the Food and Drug Administration...

FDA Reclassifies Vaginal Mesh as a High-Risk Device

Already hounded by numerous lawsuits over adverse events, manufacturers have 30 months to prove the safety and effectiveness of these devices for transvaginal repair of pelvic organ prolapse. News ...

Breaking News from Legal-Bay: Johnson & Johnson Settles for $120MM in First Big Transvaginal Mesh Settlement

PHILADELPHIA, Feb. 3, 2016 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that Johnson & Johnson has finally made its first serious attempt to start res...

Transvaginal Mesh Settlement News: J&J's Ethicon Gets Hit with $13.5MM Jury Verdict

PHILADELPHIA, Feb. 29, 2016 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that in the latest transvag...

Strengthening Surgical Mesh Safety

Two final orders from the FDA have targeted serious complications linked with surgical mesh used for transvaginal repair of pelvic organ prolapse.

Transvaginal Mesh Lawsuit News: $12.5MM Jury Verdict Reached Against Ethicon

PHILADELPHIA, Jan. 6, 2016 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reports today that a woman plaintiff was awarded $12.5 million by a Philadelphia jury. The woman ...

Ethicon Gets Hit with $12.5MM Jury Verdict in Transvaginal Mesh Case

PHILADELPHIA, Jan. 12, 2016 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that in the latest transvag...

Matching PubMed Articles

Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.

Prompted by patients' changing perceptions of transvaginal mesh, this study examines how mesh has been reported in the news following the 2011 US Food and Drug Administration (FDA) updated notificatio...

Graft and Mesh Use in Transvaginal Prolapse Repair: A Systematic Review.

To update clinical practice guidelines on graft and mesh use in transvaginal pelvic organ prolapse repair based on systematic review.

Surgeon Experience and Complications of Transvaginal Prolapse Mesh.

To measure the proportion of women with transvaginal prolapse mesh complications and their association with surgeon volume.

Risks of transvaginal mesh may be associated with an increased risk of urinary retention and reintervention.

Reoperation After Robotic and Vaginal Mesh Reconstructive Surgery: A Retrospective Cohort Study.

Our primary objective was to compare reoperations after robotic-assisted sacrocolpopexy and transvaginal mesh for apical prolapse repair. Our secondary aim was to record perioperative complications af...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement